Lies&damnedlies, rather than a dividend cap valuation, another way of looking at it:
If they grow overheads to $35m and are generating $180m revenue
= $145m gross profit at 90% margin, so $130m profit before tax and ~$100m NPAT.
What P/E ratio would be appropriate for a high growth high margin med device company?
How long is a piece of string but the answer would start with at least a 2 in front of it.
My guess is if they hit $180m its at least a $2b mkt cap company, which is about $1/sh..
IPD chart, page-656
-
- There are more pages in this discussion • 225 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
